跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBICAR S - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
IBICAR S
Approved
STANDARD
IBICAR S
Glenmark Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
074e6c182d7e4e30
Company
Glenmark Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
074e6c182d7e4e30
Drug Approval Philippines Name
IBICAR S
Product Name
IBICAR S
Registration Number
DR-XY44283
Brand Name
IBICAR S
Generic Name
SALBUTAMOL (AS SULFATE) + BECLOMETASONE DIPROPIONATE
Dosage Form
Pressurized Suspension for Inhalation
Dosage Strength
100 mcg/50 mcg per metered dose
Manufacturer
Glenmark Pharmaceuticals Ltd.
Importer
Glenmark Philippines, Inc.
Distributor
Glenmark Philippines, Inc.
Issuance Date
27 September 2024
Expiry Date
11 March 2030
Pharmacologic Category
BRONCHODILATOR/CORTICOSTEROID
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
074e6c182d7e4e30
Type
Standard
Back to Philippines FDA Approvals